News

Adderall shortage fueled by sharp rise in ADHD diagnoses

By Abigail Adcox
Published November 15, 2022 4:29pm ET
Add Washington Examiner on Google
Adderall shortage fueled by sharp rise in ADHD diagnoses
Prescriptions for Adderall are on the rise as it becomes easier for people in the United States to get diagnosed with attention-deficit/hyperactivity disorder, or ADHD, exacerbating a nationwide shortage of the stimulants. Generic and brand Adderall prescriptions skyrocketed to 41.4 million in 2021, higher than ever before, up more than 10% from 2020, according to […]

Prescriptions for Adderall are on the rise as it becomes easier for people in the United States to get diagnosed with attention-deficit/hyperactivity disorder, or ADHD, exacerbating a nationwide shortage of the stimulants.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Drugs FDA Pharmaceutical Industry